Cargando…
Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children
BACKGROUND: Compared with the general population, the immune response to COVID-19 mRNA vaccines is lower in adult kidney transplant recipients (KTRs). However, data is limited for pediatric KTRs. In this study, we aimed to assess humoral and cellular immune responses to the COVID-19 mRNA vaccine in...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716124/ https://www.ncbi.nlm.nih.gov/pubmed/36459243 http://dx.doi.org/10.1007/s00467-022-05813-w |
_version_ | 1784842613358067712 |
---|---|
author | Gulmez, Ruveyda Ozbey, Dogukan Agbas, Ayse Aksu, Bagdagul Yildiz, Nurdan Uckardes, Diana Saygili, Seha Yilmaz, Esra Karabag Yildirim, Zeynep Yuruk Tasdemir, Mehmet Kiykim, Ayca Cokugras, Haluk Canpolat, Nur Nayir, Ahmet Kocazeybek, Bekir Caliskan, Salim |
author_facet | Gulmez, Ruveyda Ozbey, Dogukan Agbas, Ayse Aksu, Bagdagul Yildiz, Nurdan Uckardes, Diana Saygili, Seha Yilmaz, Esra Karabag Yildirim, Zeynep Yuruk Tasdemir, Mehmet Kiykim, Ayca Cokugras, Haluk Canpolat, Nur Nayir, Ahmet Kocazeybek, Bekir Caliskan, Salim |
author_sort | Gulmez, Ruveyda |
collection | PubMed |
description | BACKGROUND: Compared with the general population, the immune response to COVID-19 mRNA vaccines is lower in adult kidney transplant recipients (KTRs). However, data is limited for pediatric KTRs. In this study, we aimed to assess humoral and cellular immune responses to the COVID-19 mRNA vaccine in pediatric KTRs. METHODS: This multicenter, prospective, case–control study included 63 KTRs (37 male, aged 12–21 years), 19 dialysis patients, and 19 controls. Humoral (anti-SARS-CoV2 IgG, neutralizing Ab (nAb)) and cellular (interferon-gamma release assay (IGRA)) immune responses were assessed at least one month after two doses of BNT162b2 mRNA vaccine. RESULTS: Among COVID-19 naïve KTRs (n = 46), 76.1% tested positive for anti-SARS-CoV-2 IgG, 54.3% for nAb, and 63% for IGRA. Serum levels of anti-SARS-CoV-2 IgG and nAb activity were significantly lower in KTRs compared to dialysis and control groups (p < 0.05 for all). Seropositivity in KTRs was independently associated with shorter transplant duration (p = 0.005), and higher eGFR (p = 0.007). IGRA titer was significantly lower than dialysis patients (p = 0.009). Twenty (43.4%) KTRs were positive for all immune parameters. Only four of 11 seronegative KTRs were IGRA-positive. COVID-19 recovered KTRs had significantly higher anti-SARS-CoV-2 IgG and nAb activity levels than COVID-19 naïve KTRs (p = 0.018 and p = 0.007, respectively). CONCLUSIONS: The humoral and cellular immune responses to SARS-CoV-2 mRNA BNT162b2 vaccine are lower in pediatric KTRs compared to dialysis patients. Further prospective studies are required to demonstrate the clinical efficacy of the mRNA vaccine in KTRs. This prospective study was registered in ClinicalTrials.gov (NCT05465863, registered retrospectively at 20.07.2022). GRAPHICAL ABSTRACT: [Figure: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-022-05813-w. |
format | Online Article Text |
id | pubmed-9716124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-97161242022-12-02 Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children Gulmez, Ruveyda Ozbey, Dogukan Agbas, Ayse Aksu, Bagdagul Yildiz, Nurdan Uckardes, Diana Saygili, Seha Yilmaz, Esra Karabag Yildirim, Zeynep Yuruk Tasdemir, Mehmet Kiykim, Ayca Cokugras, Haluk Canpolat, Nur Nayir, Ahmet Kocazeybek, Bekir Caliskan, Salim Pediatr Nephrol Original Article BACKGROUND: Compared with the general population, the immune response to COVID-19 mRNA vaccines is lower in adult kidney transplant recipients (KTRs). However, data is limited for pediatric KTRs. In this study, we aimed to assess humoral and cellular immune responses to the COVID-19 mRNA vaccine in pediatric KTRs. METHODS: This multicenter, prospective, case–control study included 63 KTRs (37 male, aged 12–21 years), 19 dialysis patients, and 19 controls. Humoral (anti-SARS-CoV2 IgG, neutralizing Ab (nAb)) and cellular (interferon-gamma release assay (IGRA)) immune responses were assessed at least one month after two doses of BNT162b2 mRNA vaccine. RESULTS: Among COVID-19 naïve KTRs (n = 46), 76.1% tested positive for anti-SARS-CoV-2 IgG, 54.3% for nAb, and 63% for IGRA. Serum levels of anti-SARS-CoV-2 IgG and nAb activity were significantly lower in KTRs compared to dialysis and control groups (p < 0.05 for all). Seropositivity in KTRs was independently associated with shorter transplant duration (p = 0.005), and higher eGFR (p = 0.007). IGRA titer was significantly lower than dialysis patients (p = 0.009). Twenty (43.4%) KTRs were positive for all immune parameters. Only four of 11 seronegative KTRs were IGRA-positive. COVID-19 recovered KTRs had significantly higher anti-SARS-CoV-2 IgG and nAb activity levels than COVID-19 naïve KTRs (p = 0.018 and p = 0.007, respectively). CONCLUSIONS: The humoral and cellular immune responses to SARS-CoV-2 mRNA BNT162b2 vaccine are lower in pediatric KTRs compared to dialysis patients. Further prospective studies are required to demonstrate the clinical efficacy of the mRNA vaccine in KTRs. This prospective study was registered in ClinicalTrials.gov (NCT05465863, registered retrospectively at 20.07.2022). GRAPHICAL ABSTRACT: [Figure: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-022-05813-w. Springer Berlin Heidelberg 2022-12-02 2023 /pmc/articles/PMC9716124/ /pubmed/36459243 http://dx.doi.org/10.1007/s00467-022-05813-w Text en © The Author(s), under exclusive licence to International Pediatric Nephrology Association 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Gulmez, Ruveyda Ozbey, Dogukan Agbas, Ayse Aksu, Bagdagul Yildiz, Nurdan Uckardes, Diana Saygili, Seha Yilmaz, Esra Karabag Yildirim, Zeynep Yuruk Tasdemir, Mehmet Kiykim, Ayca Cokugras, Haluk Canpolat, Nur Nayir, Ahmet Kocazeybek, Bekir Caliskan, Salim Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children |
title | Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children |
title_full | Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children |
title_fullStr | Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children |
title_full_unstemmed | Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children |
title_short | Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children |
title_sort | humoral and cellular immune response to sars-cov-2 mrna bnt162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716124/ https://www.ncbi.nlm.nih.gov/pubmed/36459243 http://dx.doi.org/10.1007/s00467-022-05813-w |
work_keys_str_mv | AT gulmezruveyda humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT ozbeydogukan humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT agbasayse humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT aksubagdagul humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT yildiznurdan humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT uckardesdiana humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT saygiliseha humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT yilmazesrakarabag humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT yildirimzeynepyuruk humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT tasdemirmehmet humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT kiykimayca humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT cokugrashaluk humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT canpolatnur humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT nayirahmet humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT kocazeybekbekir humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren AT caliskansalim humoralandcellularimmuneresponsetosarscov2mrnabnt162b2vaccineinpediatrickidneytransplantrecipientscomparedwithdialysispatientsandhealthychildren |